Single administration of novel antibody cocktail controlled patients' allergic response to cat allergen, preventing early asthma reactions for the duration of the 3-month trial Patients experienced ...

Regeneron Pharmaceuticals released positive Phase 2 trial results, which showed that a single dose of of its investigational antibody cocktail therapy prevented early asthma reactions in cat-allergic ...

Please provide your email address to receive an email when new articles are posted on . A single dose of Regeneron’s REGN1908/1909 significantly prevented reductions in FEV1 compared with placebo.